Skip to contents

The AET02_2 table provides an overview of the number of patients experiencing adverse events and the number of adverse events categorized by Body System, High Level Term and Dictionary-Derived Term.

Usage

aet02_2_main(
  adam_db,
  armvar = .study$actualarm,
  lbl_overall = .study$lbl_overall,
  prune_0 = TRUE,
  deco = std_deco("AET02"),
  .study = list(actualarm = "ACTARM", lbl_overall = NULL)
)

aet02_2_lyt(
  armvar = .study$actualarm,
  lbl_overall = .study$lbl_overall,
  lbl_aebodsys = "MedDRA System Organ Class",
  lbl_aehlt = "MedDRA High-Level Term",
  lbl_aedecod = "MedDRA Preferred Term",
  deco = std_deco("AET02"),
  .study = list(actualarm = "ACTARM", lbl_overall = NULL)
)

aet02_2_pre(adam_db, ...)

aet02_2

aet02_3_main(
  adam_db,
  armvar = .study$actualarm,
  lbl_overall = .study$lbl_overall,
  prune_0 = TRUE,
  deco = std_deco("AET02"),
  .study = list(actualarm = "ACTARM", lbl_overall = NULL)
)

Format

An object of class chevron_tlg of length 1.

Arguments

adam_db

(dm) object containing the ADaM datasets

armvar

(character) variable used for column splitting

lbl_overall

(character) label used for overall column, if set to NULL the overall column is omitted

prune_0

(logical) remove 0 count rows

deco

(character) decoration with title, subtitles and main_footer content

.study

(list) with default values for the arguments of the function

lbl_aebodsys

(character) text label for AEBODSYS.

lbl_aehlt

(character) text label for AEHLT.

lbl_aedecod

(character) text label for AEDECOD.

...

not used.

Details

  • Numbers represent absolute numbers of patients and fraction of N, or absolute number of event when specified.

  • Remove zero-count rows unless overridden with prune_0 = FALSE.

  • Split columns by arm.

  • Does not include a total column by default.

  • Sort Body System or Organ Class, High Level Term and Dictionary-Derived Term hierarchically by highest overall frequencies.

  • Missing values of AEBODSYS, AEHLT and AEDECOD in adae are labeled by No Coding available.

  • Numbers represent absolute numbers of patients and fraction of N, or absolute number of event when specified.

  • Remove zero-count rows unless overridden with prune_0 = FALSE.

  • Split columns by arm.

  • Does not include a total column by default.

  • Sort Dictionary-Derived Code by highest overall frequencies.

  • Missing values of AEDECOD in aead are labeled by No Coding available.

Functions

  • aet02_2_main(): Main TLG function

  • aet02_2_lyt(): Layout

  • aet02_2_pre(): Preprocessing

  • aet02_3_main(): Main TLG function

Examples

run(aet02_2, syn_test_data())
#> MedDRA System Organ Class                                                                               
#>   MedDRA High-Level Term                                       A: Drug X    B: Placebo    C: Combination
#>     MedDRA Preferred Term                                       (N=134)       (N=134)        (N=132)    
#> ————————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one adverse event       122 (91%)    123 (91.8%)    120 (90.9%)  
#> Overall total number of events                                    609           622            703      
#> cl A.1                                                                                                  
#>   Total number of patients with at least one adverse event     78 (58.2%)    75 (56%)       89 (67.4%)  
#>   Total number of events                                          132           130            160      
#>   hlt A.1.1.1                                                                                           
#>     Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)  
#>     Total number of events                                        132           130            160      
#>     dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)  
#>     dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)  
#> cl B.2                                                                                                  
#>   Total number of patients with at least one adverse event      79 (59%)    74 (55.2%)      85 (64.4%)  
#>   Total number of events                                          129           138            143      
#>   hlt B.2.2.3                                                                                           
#>     Total number of patients with at least one adverse event   48 (35.8%)   54 (40.3%)      51 (38.6%)  
#>     Total number of events                                         64           76              77      
#>     dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)  
#>   hlt B.2.1.2                                                                                           
#>     Total number of patients with at least one adverse event   49 (36.6%)   44 (32.8%)      52 (39.4%)  
#>     Total number of events                                         65           62              66      
#>     dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)  
#> cl D.1                                                                                                  
#>   Total number of patients with at least one adverse event      79 (59%)     67 (50%)       80 (60.6%)  
#>   Total number of events                                          127           106            135      
#>   hlt D.1.1.1                                                                                           
#>     Total number of patients with at least one adverse event   50 (37.3%)   42 (31.3%)      51 (38.6%)  
#>     Total number of events                                         61           51              71      
#>     dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)  
#>   hlt D.1.1.4                                                                                           
#>     Total number of patients with at least one adverse event   48 (35.8%)   42 (31.3%)      50 (37.9%)  
#>     Total number of events                                         66           55              64      
#>     dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)  
#> cl D.2                                                                                                  
#>   Total number of patients with at least one adverse event     47 (35.1%)   58 (43.3%)      57 (43.2%)  
#>   Total number of events                                           62           72              74      
#>   hlt D.2.1.5                                                                                           
#>     Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)  
#>     Total number of events                                         62           72              74      
#>     dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)  
#> cl B.1                                                                                                  
#>   Total number of patients with at least one adverse event     47 (35.1%)   49 (36.6%)      43 (32.6%)  
#>   Total number of events                                           56           60              62      
#>   hlt B.1.1.1                                                                                           
#>     Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)  
#>     Total number of events                                         56           60              62      
#>     dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)  
#> cl C.2                                                                                                  
#>   Total number of patients with at least one adverse event     35 (26.1%)   48 (35.8%)      55 (41.7%)  
#>   Total number of events                                           48           53              65      
#>   hlt C.2.1.2                                                                                           
#>     Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)  
#>     Total number of events                                         48           53              65      
#>     dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)  
#> cl C.1                                                                                                  
#>   Total number of patients with at least one adverse event     43 (32.1%)   46 (34.3%)      43 (32.6%)  
#>   Total number of events                                           55           63              64      
#>   hlt C.1.1.1                                                                                           
#>     Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)  
#>     Total number of events                                         55           63              64      
#>     dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)